P-941 Phase II study of gefitinib (IRESSA) administered as first linetreatment in patients with non-resectable, pneumonic-type adenocarcinoma (P-ADC)

✍ Scribed by Cadranel, J.; Debove, P.; Quoix, E.; Soria, J.; Friard, S.; Perol, M.; Souquet, P.; Vergnenegre, A.; Morot-Sibilot, D.; Milleron, B.

• Book ID: 123478025
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 152 KB
• Volume: 49
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/S0169-5002(05)81434-5